Lv66
1890 积分 2025-09-11 加入
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
1天前
待确认
Double-edged roles of protein tyrosine phosphatase SHP2 in cancer and its inhibitors in clinical trials
28天前
已完结
Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes
29天前
已完结
Remodeling of T and endothelial cells during total neoadjuvant therapy in rectal cancer
2个月前
已完结
Active learning framework leveraging transcriptomics identifies modulators of disease phenotypes
2个月前
已完结
Homeostatic maturation programs drive human cDC2s into a tolerogenic state
2个月前
已完结
TIM-3 restrains anti-tumour immunity by regulating inflammasome activation
5个月前
已完结
T lymphocyte–specific deletion of SHP1 and SHP2 promotes activation-induced cell death of CD4 + T cells and impairs antitumor response
6个月前
已完结
JAB-3312, a Potent Allosteric SHP2 Inhibitor That Enhances the Efficacy of RTK/RAS/MAPK and PD-1 Blockade Therapies
6个月前
已完结
Ferroptosis Induction Enhances Anti-PD-1 Efficacy in NSCLC via HIF-1α/PD-L1 Modulation
7个月前
已完结
皖公网安备34019202002308
